Skye Bioscience, Inc. (SKYE)
0.8193
+0.02
(+2.48%)
USD |
NASDAQ |
Feb 06, 16:00
0.8161
0.00 (0.00%)
Pre-Market: 08:50
Skye Bioscience SG&A Expense (TTM) : 16.93M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Assertio Holdings, Inc. | 63.52M |
| Eli Lilly & Co. | 11.09B |
| Theravance Biopharma, Inc. | 75.94M |
| Viking Therapeutics, Inc. | 52.36M |
| Kyntra Bio, Inc. | 28.80M |